Clinical Trials Directory

Trials / Completed

CompletedNCT02050893

The Effect of Midazolam on Fluid Responsiveness in Septic Patients

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Southeast University, China · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Fluid resuscitation remains the foundation for septic treatment.The evaluation of fluid responsiveness has significance in volume resuscitation for septic shock patients. As the sedative which is commonly used in ICU, Midazolam is supposed to change fluid responsiveness for the pharmacological effect of venodilation. However, the hypothesis has not been certified clinically. In this research, the investigators aim to test the hypothesis that Midazolam can increase fluid responsiveness(using passive leg raising test) in septic shock patients.

Conditions

Interventions

TypeNameDescription
DRUGsedatives(Midazolam and Propofol)

Timeline

Start date
2012-05-01
Primary completion
2013-04-01
Completion
2013-04-01
First posted
2014-01-31
Last updated
2014-01-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02050893. Inclusion in this directory is not an endorsement.

The Effect of Midazolam on Fluid Responsiveness in Septic Patients (NCT02050893) · Clinical Trials Directory